These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1754593)
41. [Approach to chemotherapy of vertebral tuberculosis]. Li YD Zhonghua Jie He He Hu Xi Za Zhi; 1990 Apr; 13(2):72-3, 125. PubMed ID: 2397533 [TBL] [Abstract][Full Text] [Related]
42. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916 [TBL] [Abstract][Full Text] [Related]
43. [Effectiveness of intermittent chemotherapy in the combined treatment of patients with recently diagnosed destructive tuberculosis of the lungs]. Osiĭnskiĭ IIu; Berezovskiĭ BA Probl Tuberk; 1989; (5):56-9. PubMed ID: 2748559 [No Abstract] [Full Text] [Related]
44. [Blood coagulation state in destructive pulmonary tuberculosis patients under different methods of chemotherapy]. Sagalovich VIa; Beresneva RE; Ivanova VB Probl Tuberk; 1981 May; (5):30-4. PubMed ID: 7255385 [No Abstract] [Full Text] [Related]
45. Filtrable forms of mycobacteria tuberculosis. Khomenko AG; Golyshevskaya VI Z Erkr Atmungsorgane; 1984; 162(2):147-54. PubMed ID: 6429959 [TBL] [Abstract][Full Text] [Related]
46. [Indicators of antibody formation in patients with pulmonary tuberculosis and drug-resistant Mycobacteria]. Evdokimov VN Probl Tuberk; 1988; (9):44-7. PubMed ID: 3148135 [No Abstract] [Full Text] [Related]
47. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119 [TBL] [Abstract][Full Text] [Related]
48. [Detection of antituberculosis antibodies and antigens by enzyme immunoassay in young and preschool children suffering from tuberculosis]. Bogdanova EV; Kulikovskaia NV; Baenskiĭ AV; Gavrilov AA; Kalinina OA; Kapina MA; Dem'ianenko NV Probl Tuberk; 1998; (6):21-3. PubMed ID: 10067344 [TBL] [Abstract][Full Text] [Related]
51. [Ambulatory intermittent chemotherapy of patients with newly detected pulmonary tuberculosis]. Rudoĭ NM; Simonian LK Klin Med (Mosk); 1973 Jul; 51(7):89-92. PubMed ID: 4786268 [No Abstract] [Full Text] [Related]
52. Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months. Am Rev Respir Dis; 1977 Nov; 116(5):807-20. PubMed ID: 411405 [No Abstract] [Full Text] [Related]
53. Intermittent short course treatment of pulmonary tuberculosis: preliminary report. Corradini A; Isekson I; Deck C; Fernandez M; Zamorano T; Farga V Bull Int Union Tuberc; 1976; 51(1):103-6. PubMed ID: 1030268 [No Abstract] [Full Text] [Related]
54. [Determination of tuberculosis antibodies using an immunoenzyme assay in lyophilized samples of capillary blood]. Vishnevskaia EB Lab Delo; 1991; (6):38-40. PubMed ID: 1717752 [TBL] [Abstract][Full Text] [Related]
55. [Bacillary elimination in patients with destructive pulmonary tuberculosis treated with intrabronchial infusion of tuberculostatics]. Ogiĭ NV Probl Tuberk; 1979 Jul; (7):24-9. PubMed ID: 116218 [No Abstract] [Full Text] [Related]
56. [Dynamics of pulmonary tuberculosis during hospital-stage chemotherapy of different duration]. Kunitskiĭ EM Probl Tuberk; 1978 Aug; (8):18-22. PubMed ID: 704577 [No Abstract] [Full Text] [Related]
57. [Antituberculosis antibodies to 3 chemical substances from the causative agent in tuberculosis patients]. Kaplin NN; Volkon VM; Krivokhizh VN; Golovacheva SN Probl Tuberk; 1977 Jul; (7):66-9. PubMed ID: 408810 [No Abstract] [Full Text] [Related]
58. [Significance of determination of antibodies to mycobacterial nucleoproteins in tuberculosis]. Sachkov VI; Tikhonov VA Probl Tuberk; 1977 May; (5):61-3. PubMed ID: 406611 [No Abstract] [Full Text] [Related]
59. Enzyme immunoassay to detect antituberculous glycolipid antigen (anti-TBGL antigen) antibodies in serum for diagnosis of tuberculosis. Kawamura M; Sueshige N; Imayoshi K; Yano I; Maekura R; Kohno H J Clin Lab Anal; 1997; 11(3):140-5. PubMed ID: 9138102 [TBL] [Abstract][Full Text] [Related]
60. Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients. Sethna KB; Mistry NF; Dholakia Y; Antia NH; Harboe M Scand J Infect Dis; 1998; 30(4):363-9. PubMed ID: 9817516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]